Novavax, Inc. (NVAX)
NASDAQ·Healthcare·Biotechnology
$8.88
-2.16%
Mkt Cap $1.46B
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (8 analysts)
$18.00
Range $11.00 – $25.00
Implied Upside
+102.7%
Consensus $18.00 vs current $8.88
NASDAQ·Healthcare·Biotechnology
$8.88
-2.16%
Mkt Cap $1.46B
Buy
2
Hold
1
Sell
0
Price Target (8 analysts)
$18.00
Range $11.00 – $25.00
+102.7%
Consensus $18.00 vs current $8.88